Insider Title Company Date Price Return Shares Value
Mcintyre David Chief Financial Officer Avita Therapeutics, Inc. (RCEL) 2020-07-17 $23.20 -61.6% 693 $16,076
Return Profit / (loss) Cost
Total -61.6% $-9,908 $16,076